SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-14-054864
Filing Date
2014-02-14
Accepted
2014-02-14 16:24:54
Documents
2
Group Members
VENROCK ASSOCIATES II, L.P.VENROCK ASSOCIATES V, L.P.VENROCK ENTREPRENEURS FUND, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS, L.P.VENROCK MANAGEMENT V, LLCVENROCK PARTNERS MANAGEMENT V, LLCVENROCK PARTNERS V, L.P.VHCP CO-INVESTMENT HOLDINGS, LLCVHCP MANAGEMEN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d676712dsc13ga.htm SC 13G/A 246578
2 EX-99.1 d676712dex991.htm EX-99.1 16789
  Complete submission text file 0001193125-14-054864.txt   265225
Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

IRS No.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Subject) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-85292 | Film No.: 14617083
SIC: 2834 Pharmaceutical Preparations